Showing posts with label Covid aid. Show all posts
Showing posts with label Covid aid. Show all posts

Tuesday, 1 June 2021

Pandemic relief policies need more resources, better design

‘Pandemic relief measures in developing countries have been limited by modest resources, fear of financial market discipline and policy mimicry. COVID-19 has triggered not only an international public health emergency, but also a global economic crisis, setting back decades of uneven progress, especially in developing countries.’

This story is well argued and contains several relevant and informative links under the following subheadings:

  • Struggling to cope
  • Urgent financing needs
  • COVID-19 recessions different
  • Government as ‘payer-of-last-resort’
  • Policy blind spots
  • Diverging recoveries
  • Appropriate relief measures
  • Recoveries threatened
Read here (IPS News, Jun 1, 2021)

 

Tuesday, 25 May 2021

Developing countries desperately need Covid-19 financing

‘Failure to sufficiently accelerate comprehensive efforts to contain COVID-19 contagion has greatly worsened the catastrophe in developing countries. Grossly inadequate financing of relief, recovery and reform efforts has also further set back progress, including sustainable development.’

This story is well argued and contains several relevant and informative links under the following subheadings:

  • Uncertain and unequal recovery
  • Global disparities
  • Insufficient international support
  • Leveraging the new SDRs
  • Financing options for developing countries

Read here (IPS News, May 25, 2021)

Friday, 12 March 2021

US and allies (India, Australia and Japan) promise one billion jabs for South East Asia

‘The leaders of the US, Australia, India and Japan have agreed to deliver one billion doses of coronavirus vaccine to much of Asia by the end of 2022. The joint commitment was made following the first leaders' meeting of the so-called Quad - a group formed in 2007. The vaccines - expected to be the single-dose Johnson & Johnson product - are set to be manufactured in India.’

Read here (BBC, Mar 13, 2021)

Tuesday, 9 March 2021

Prioritise pandemic relief, recovery: No time for debt buybacks

‘Developing country governments are being wrongly advised to use their modest fiscal resources to pay down accumulated debt instead of strengthening pandemic relief and recovery. Thus, debt phobia risks deepening and extending COVID-19 recessions by prioritising buybacks...

‘With ‘collective action’ complications affecting negotiations, and the greater number and variety of heavily indebted countries and creditors, equitable debt buybacks are impossible to negotiate. Worse, prioritising buybacks means rejecting former debt hawk Reinhart’s current pragmatic advice to “First fight the war, then figure out how to pay for it”.

‘The urgent priority is for fiscal resources to strengthen relief, recovery and reform measures. Prioritising debt buybacks, instead of urgently augmenting fiscal resources, may thus contribute to another “lost decade” or worse.’

Read here (IPS News, March 9, 2021)

Sunday, 7 March 2021

India’s Covid vaccine rollout ‘rescued the world’: Top US scientist

‘Dr Peter Hotez, Dean of the National School of Tropical Medicine at Baylor College of Medicine (BCM) in Houston during a recent webinar said that the two mRNA vaccines may not impact the world's low- and middle-income countries, but India's vaccines, made in collaboration with universities across the world such as BCM and the Oxford University, have "rescued the world" and its contributions must not be underestimated.

‘During the webinar, "Covid-19: Vaccination and Potential Return to Normalcy - If and When", Dr Hotez, an internationally-recognised physician-scientist in neglected tropical diseases and vaccine development, said that the Covid-19 vaccine rollout is "India's gift'' to the world in combating the virus.

‘India's drugs regulator gave emergency use authorisation to Covishield, produced by Pune-based Serum Institute of India after securing licence from British pharma company AstraZeneca, and Covaxin, indigenously developed jointly by Hyderabad-based Bharat Biotech and Indian Council of Medical Research scientists.’

Read here (India Today, Mar 7, 2021)

Thursday, 4 March 2021

China’s vaccine diplomacy falls flat in the Philippines

‘The Philippines has finally kicked off its Covid-19 vaccine rollout with much-publicized donations from China but rising controversies around the rollout will prevent Beijing from declaring a “vaccine diplomacy” win.

‘China recently delivered 600,000 doses of the vaccine developed by the Beijing-based company Sinovac Biotech and frontliners across the country are set to be among the primary beneficiaries. The drive kicks off as the Philippines grapples with one of the region’s worst outbreaks and steepest economic recessions caused by extended lockdowns.’

Read here (Asia Times, Mar 4, 2021)

Tuesday, 2 March 2021

China ships millions of Covid-19 vaccines to poor nations abroad; denies ‘vaccine diplomacy’

‘China's vaccine diplomacy campaign has been a surprising success: It has pledged roughly half a billion doses of its vaccines to more than 45 countries, according to a country-by-country tally by The Associated Press. With just four of China's many vaccine makers claiming they are able to produce at least 2.6 billion doses this year, a large part of the world's population will end up inoculated not with the fancy Western vaccines boasting headline-grabbing efficacy rates, but with China's humble, traditionally made shots.

‘Amid a dearth of public data on China's vaccines, hesitations over their efficacy and safety are still pervasive in the countries depending on them, along with concerns about what China might want in return for deliveries. Nonetheless, inoculations with Chinese vaccines already have begun in more than 25 countries, and the Chinese shots have been delivered to another 11, according to the AP tally, based on independent reporting in those countries along with government and company announcements.’

Read here (CP24, Mar 2, 2021)

Saturday, 20 February 2021

Covid vaccines: G7 increase support for Covax scheme

‘G7 leaders have pledged to intensify co-operation on Covid-19 and increase their contribution to the Covax vaccine-sharing initiative. In a joint statement released after a virtual summit on Friday, G7 leaders raised their overall commitment to $7.5bn (£5.3bn). Wealthy countries are facing growing pressure to make sure lower-income nations get fair access to vaccines.’

Read here (BBC, Feb 20, 2021)

Tuesday, 19 January 2021

India to send Covaxin, Covishield to other nations as goodwill gesture

‘India has decided to export 8.1 lakh doses of Covaxin to Oman, Mongolia, Myanmar, Bahrain, Mauritius, the Philippines and the Maldives as a goodwill gesture, people in the know said. Government sources said Serum would supply a few lakh doses of Covishield to the Seychelles, Afghanistan, Bangladesh, Bhutan and Nepal.’

Read here (Economic Times, Jan 19, 2021)

Sunday, 27 December 2020

Vaccine diplomacy not as simple as a shot in the arm

‘Concerns including dearth of vaccine data and perceived use for geopolitical goals stand in the way of China's soft power push...

‘Rich nations have bought almost all of next year's supply of the two vaccine front runners - one by Pfizer-BioNTech and the other by Moderna - according to the People's Vaccine Alliance (PVA), a network of organisations that includes Amnesty International, Oxfam and Global Justice Now. Canada, for instance, has ordered enough vaccines to inoculate each Canadian five times, although it has pledged to share any excess with other countries.

‘The situation is such that nine in 10 people in 67 developing countries - including nations like Cambodia, Laos and Pakistan - stand little chance of being vaccinated next year, said the PVA this month. To these countries, China's vaccines are a lifesaver.’

Read here (Straits Times, Dec 28, 2020)

Sunday, 13 September 2020

Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly

Executive summary: ‘The Lancet COVID-19 Commission was launched on July 9, 2020, to assist governments, civil society, and UN institutions in responding effectively to the COVID-19 pandemic. The Commission aims to offer practical solutions to the four main global challenges posed by the pandemic: suppressing the pandemic by means of pharmaceutical and non-pharmaceutical interventions; overcoming humanitarian emergencies, including poverty, hunger, and mental distress, caused by the pandemic; restructuring public and private finances in the wake of the pandemic; and rebuilding the world economy in an inclusive, resilient, and sustainable way that is aligned with the Sustainable Development Goals (SDGs) and the Paris Climate Agreement. Many creative solutions are already being implemented, and a key aim of the Commission is to accelerate their adoption worldwide.’

Download full statement here (Sept 14, 2020)

Tuesday, 21 July 2020

EU leaders reach recovery deal after marathon summit

‘Tempers were often frayed during the negotiations. The "frugal four", Sweden, Denmark, Austria and the Netherlands, along with Finland had opposed extending €500bn in grants. The group originally set €375bn as the limit. Other members, such as Spain and Italy, did not want to go below €400bn. At one point French President Emmanuel Macron reportedly banged his fists on the table, as he told the "frugal four" they were putting the European project in danger...

‘Another issue was over linking aid to the "rule of law". Hungary and Poland both threatened to veto the package if it adopted a policy of withholding funds from nations deemed to fall short of democratic principles.’

Read here (BBC, July 21, 2020)

Friday, 17 July 2020

UN makes record $10.3bn appeal for pandemic fight: Up to 265m people could face starvation by end-2020

‘The United Nations is making an appeal for $10.3 billion (£8.2 billion) to help fight the coronavirus pandemic, its largest ever fundraising call. The UN says up to 265 million people could face starvation by the end of the year because of the impact of Covid-19. The money will be for used for low income and fragile countries.’

Read here (BBC, July 17, 2020)

Saturday, 20 June 2020

Coronavirus: China’s belt and road partners call for more cooperation on public health

‘Senior officials from 25 nations involved with China’s multibillion-dollar Belt and Road Initiative have issued a joint statement calling for great cooperation on public health as the world continues to battle the Covid-19 pandemic. Ensuring fair access to health products and services should be the world’s top priority, the minister-level officials said in a communique released by China’s foreign ministry on Friday following an international videoconference. They also called for greater investment in “sound and resilient” health infrastructure – including the construction of regional storage centres for medical supplies – and committed to improving the availability and affordability of “products of reliable quality”, especially vaccines, drugs and other essential items.’

Read here (South China Morning Post, June 20, 2020)

Monday, 18 May 2020

Fighting Covid-19 through solidarity and cooperation building a global community of health for all

In his statement at the virtual opening of the 73rd World Health Assembly, Xi Jinping, China's president, announced the following:

— China will provide US$2 billion over two years to help with COVID-19 response and with economic and social development in affected countries, especially developing countries.

— China will work with the UN to set up a global humanitarian response depot and hub in China, ensure the operation of anti-epidemic supply chains and foster “green corridors” for fast-track transportation and customs clearance.   

— China will establish a cooperation mechanism for its hospitals to pair up with 30 African hospitals and accelerate the building of the Africa CDC headquarters to help the continent ramp up its disease preparedness and control capacity.

— COVID-19 vaccine development and deployment in China, when available, will be made a global public good. This will be China’s contribution to ensuring vaccine accessibility and affordability in developing countries.

— China will work with other G20 members to implement the Debt Service Suspension Initiative for the poorest countries. China is also ready to work with the international community to bolster support for the hardest-hit countries under the greatest strain of debt service, so that they could tide over the current difficulties.

Read full speech here (Global Times, May 18, 2020)

Sunday, 17 May 2020

China’s aggressive approach to coronavirus criticism ‘not working’

‘Observers call for Beijing to reflect on shortcomings of its engagement with the rest of the world as international sympathy fades. Mask diplomacy and bellicose statements need to go if global relations are to improve, they say.’

Read here (South China Morning Post, May 17, 2020)

Monday, 4 May 2020

UN humanitarian chief: After COVID-19, it’s in everyone’s interest to help the world's poorest countries

‘Our best estimate is that the cost of protecting the most vulnerable 10 per cent of people in the world’s poorest countries from the very worst impacts of the pandemic is approximately $90 billion. $90 billion is a lot of money. But it is an affordable sum of money. It is equivalent to just 1 per cent of the global stimulus package the world’s richest countries have put in place to save the global economy...

‘Some may be sceptical that additional resources of that magnitude can be generated in the current circumstances. That is not my experience. After the financial crisis of 2008 fundraising for UN-coordinated humanitarian appeals had increased by more than 40 per cent by 2010. That was a result of human generosity and empathy – but also a calculation of national interest in the donor countries.’

Read here (OCHA, May 4, 2020)

Friday, 1 May 2020

Ethiopia’s Prime Minister calls on developed countries to help Africa through Covid-19

Ethiopian Prime Minister Abiy Ahmed calls on developed countries to help Africa through the coronavirus pandemic. The continent has low levels of healthcare spending and will struggle to implement social distancing measures. Ahmed calls for debt relief measures and additional financial aid packages from the IMF.

Read here (Project Syndicate, May 1, 2020)

Tuesday, 14 April 2020

First UN solidarity flight departs Addis Ababa carrying vital COVID-19 medical supplies to all African nations

‘The first United Nations “Solidarity Flight” is scheduled to leave Addis Ababa, Ethiopia, today [April 14] - from there, the aircraft will transport the vital medical cargo to all countries in Africa, where supplies are desperately needed to contain the spread of COVID-19. WHO cargo is being  transported by the United Nations World Food Programme (WFP), and includes face shields, gloves, goggles, gowns, masks, medical aprons and thermometers, as well as ventilators.’

Read here (WHO, April 14, 2020)

Thursday, 2 April 2020

China rolls out the Health Silk Road

 ‘In a graphic demonstration of soft power, so far China has offered Covid-19-related equipment and medical help to no fewer than 89 nations – and counting...

‘That covers Africa (especially South Africa, Namibia and Kenya, with Alibaba in fact announcing it will send help to all African nations); Latin America (Brazil, Argentina, Venezuela, Peru); the arc from East Asia to Southwest Asia; and Europe...

‘Key recipients in Europe include Italy, France, Spain, Belgium, the Netherlands, Serbia and Poland. But Italy, most of all, is a very special case. Most are donations. Some are trade – like millions of masks sold to France (and the US)...

‘This Chinese soft power offensive is carefully calibrated to offset the current paralysis of global supply chains. China is now working overtime to supply many parts of the world with medicine and related healthcare items – always with the Belt and Road framework in mind, as if doubling down on Globalization 2.0.’

Read here (Asia Times, April 2, 2020)

Worst ever Covid variant? Omicron

John Campbell shares his findings on Omicron.  View here (Youtube, Nov 27, 2021)